Comparison of integron-linked antibiotic resistance genes in strains of Salmonella spp. isolated from swine in Chile in 2005 and 2008

Canadian Journal of Microbiology
Lisette LapierreConsuelo Borie

Abstract

Salmonella spp. isolates obtained from healthy swine in 2008 were analyzed for antibiotic resistance phenotypes and genotypes. The resistance profiles of the 2008 isolates were compared with those of a Salmonella collection isolated from the same geographical area in 2005. The 2008 isolates consisted of strains that were 97% oxytetracycline resistant, 33.3% amoxicillin resistant, 31.8% amoxicillin- plus clavulanic acid resistant, 27.5% trimethoprim-sulfamethoxazole resistant, 17.3% streptomycin resistant, and 7.2% enrofloxacin-ciprofloxacin resistant. The presence of integrons and resistance genes and their topological association in resistant strains was assessed by PCR. The prevalence of class 1 integrons was the highest, at 46.2%, while class 2 integrons were present in 17.9% of the isolates. In strains that harboured class 1 integrons, we identified 3 different gene cassette arrangements; a single class 2 integron arrangement of dfrA1-sat1-aadA1 was found. Comparison of these results with data obtained from the 2005 isolates showed that Salmonella strains resistant to amoxicillin and amoxicillin plus clavulanic acid had clearly emerged over the span of 3 years, along with an increase in the prevalence of class 1 integrons a...Continue Reading

References

Jul 4, 2001·Veterinary Research·A Carattoli
Jan 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·T M L'Abée-Lund, H Sørum
May 20, 2004·The Journal of Antimicrobial Chemotherapy·Wondwossen A GebreyesCraig Altier
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Hedi MammeriPatrice Nordmann
Apr 20, 2005·FEMS Microbiology Letters·Marilyn C Roberts
May 24, 2005·FEMS Immunology and Medical Microbiology·Erica L FonsecaAna C P Vicente
Sep 3, 2005·Nature Reviews. Microbiology·Christopher M Thomas, Kaare M Nielsen
Nov 18, 2005·Veterinary Microbiology·Geovana Brenner MichaelStefan Schwarz
Dec 21, 2005·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·M Vieira-PintoC Martins
Mar 28, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Emmanouil GalanakisYiannis Tselentis
Feb 20, 2007·Veterinary Microbiology·Xian-Zhi LiLateef Adewoye
Mar 27, 2007·Cell·Michael N Alekshun, Stuart B Levy
Nov 26, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jonathan G FryeMarkus Rose
May 27, 2009·The Lancet Infectious Diseases·Pål J JohnsenKaare M Nielsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.